1. Home
  2. OCS vs ORC Comparison

OCS vs ORC Comparison

Compare OCS & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • ORC
  • Stock Information
  • Founded
  • OCS 2003
  • ORC 2010
  • Country
  • OCS Switzerland
  • ORC United States
  • Employees
  • OCS N/A
  • ORC N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • ORC Real Estate Investment Trusts
  • Sector
  • OCS Health Care
  • ORC Real Estate
  • Exchange
  • OCS Nasdaq
  • ORC Nasdaq
  • Market Cap
  • OCS 869.8M
  • ORC 1.0B
  • IPO Year
  • OCS N/A
  • ORC 2013
  • Fundamental
  • Price
  • OCS $21.71
  • ORC $7.53
  • Analyst Decision
  • OCS Strong Buy
  • ORC Hold
  • Analyst Count
  • OCS 4
  • ORC 2
  • Target Price
  • OCS $41.00
  • ORC N/A
  • AVG Volume (30 Days)
  • OCS 77.9K
  • ORC 5.2M
  • Earning Date
  • OCS 11-06-2025
  • ORC 10-23-2025
  • Dividend Yield
  • OCS N/A
  • ORC 19.65%
  • EPS Growth
  • OCS N/A
  • ORC N/A
  • EPS
  • OCS N/A
  • ORC 0.07
  • Revenue
  • OCS $960,668.00
  • ORC $24,257,000.00
  • Revenue This Year
  • OCS $36.75
  • ORC $75.23
  • Revenue Next Year
  • OCS $1,261.53
  • ORC $53.72
  • P/E Ratio
  • OCS N/A
  • ORC $103.42
  • Revenue Growth
  • OCS N/A
  • ORC N/A
  • 52 Week Low
  • OCS $14.00
  • ORC $5.69
  • 52 Week High
  • OCS $23.08
  • ORC $9.01
  • Technical
  • Relative Strength Index (RSI)
  • OCS 76.98
  • ORC 68.53
  • Support Level
  • OCS $21.19
  • ORC $7.22
  • Resistance Level
  • OCS $21.79
  • ORC $7.36
  • Average True Range (ATR)
  • OCS 0.66
  • ORC 0.13
  • MACD
  • OCS 0.28
  • ORC 0.04
  • Stochastic Oscillator
  • OCS 93.88
  • ORC 99.03

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

Share on Social Networks: